Plant production of recombinant antigens containing the receptor binding domain (RBD) of two SARS-CoV-2 variants
- PMID: 39066957
- DOI: 10.1007/s10529-024-03517-9
Plant production of recombinant antigens containing the receptor binding domain (RBD) of two SARS-CoV-2 variants
Abstract
Objectives: The aim of this work was to rapidly produce in plats two recombinant antigens (RBDw-Fc and RBDo-Fc) containing the receptor binding domain (RBD) of the spike (S) protein from SARS-CoV-2 variants Wuhan and Omicron as fusion proteins to the Fc portion of a murine IgG2a antibody constant region (Fc).
Results: The two recombinant antigens were expressed in Nicotiana benthamiana plants, engineered to avoid the addition of N-linked plant-typical sugars, through vacuum agroinfiltration and showed comparable purification yields (about 35 mg/kg leaf fresh weight).
Conclusions: Their Western blotting and Coomassie staining evidenced the occurrence of major in planta proteolysis in the region between the RBD and Fc, which was particularly evident in RBDw-Fc, the only antigen bearing the HRV 3C cysteine protease recognition site. The two RBD N-linked glycosylation sites showed very homogeneous profiles free from plant-typical sugars, with the most abundant glycoform represented by the complex sugar GlcNAc4Man3. Both antigens were specifically recognised in Western Blot analysis by the anti-SARS-CoV-2 human neutralizing monoclonal antibody J08-MUT and RBDw-Fc was successfully used in competitive ELISA experiments for binding to the angiotensin-converting enzyme 2 receptor to verify the neutralizing capacity of the serum from vaccinated patients. Both SARS-Cov-2 antigens fused to a murine Fc region were rapidly and functionally produced in plants with potential applications in diagnostics.
Keywords: COVID19; Molecular farming; Proteolytic degradation; SARS-CoV-2; Transient expression.
© 2024. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
Plant-Produced Glycosylated and In Vivo Deglycosylated Receptor Binding Domain Proteins of SARS-CoV-2 Induce Potent Neutralizing Responses in Mice.Viruses. 2021 Aug 12;13(8):1595. doi: 10.3390/v13081595. Viruses. 2021. PMID: 34452461 Free PMC article.
-
Plant-produced SARS-CoV-2 receptor binding domain (RBD) variants showed differential binding efficiency with anti-spike specific monoclonal antibodies.PLoS One. 2021 Aug 11;16(8):e0253574. doi: 10.1371/journal.pone.0253574. eCollection 2021. PLoS One. 2021. PMID: 34379620 Free PMC article.
-
Enhanced elicitation of potent neutralizing antibodies by the SARS-CoV-2 spike receptor binding domain Fc fusion protein in mice.Vaccine. 2020 Oct 27;38(46):7205-7212. doi: 10.1016/j.vaccine.2020.09.058. Epub 2020 Sep 22. Vaccine. 2020. PMID: 33010978 Free PMC article.
-
Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies.Biomed Pharmacother. 2020 Oct;130:110559. doi: 10.1016/j.biopha.2020.110559. Epub 2020 Aug 1. Biomed Pharmacother. 2020. PMID: 32768882 Free PMC article. Review.
-
Mutations in the SARS-CoV-2 spike receptor binding domain and their delicate balance between ACE2 affinity and antibody evasion.Protein Cell. 2024 May 28;15(6):403-418. doi: 10.1093/procel/pwae007. Protein Cell. 2024. PMID: 38442025 Free PMC article. Review.
References
-
- Andreano E, Nicastri E, Paciello I, Pileri P, Manganaro N, Piccini G, Manenti A, Pantano E, Kabanova A, Troisi M, Vacca F, Cardamone D, De Santi C, Torres JL, Ozorowski G, Benincasa L, Jang H, Di Genova C, Depau L, Brunetti J, Agrati C, Capobianchi MR, Castilletti C, Emiliozzi A, Fabbiani M, Montagnani F, Bracci L, Sautto G, Ross TM, Montomoli E, Temperton N, Ward AB, Sala C, Ippolito G, Rappuoli R (2021) Extremely potent human monoclonal antibodies from COVID-19 convalescent patients. Cell 184:1821–1835. https://doi.org/10.1016/j.cell.2021.02.035 - DOI - PubMed - PMC
-
- Capell T, Twyman RM, Armario-Najera V, Ma JK, Schillberg S, Christou P (2020) Potential applications of plant biotechnology against SARS-CoV-2. Trends Plant Sci 25:635–643. https://doi.org/10.1016/j.tplants.2020.04.009 - DOI - PubMed - PMC
-
- Ceballo Y, López A, González CE, Ramos O, Andújar I, Martínez RU, Hernández A (2022) Transient production of receptor- binding domain of SARS-CoV-2 in Nicotiana benthamiana plants induces specific antibodies in immunized mice. Mol Biol Re 49:6113–6123. https://doi.org/10.1007/s11033-022-07402-4 - DOI
-
- Diego-Martin B, González B, Vazquez-Vilar M, Selma S, Mateos-Fernández R, Gianoglio S, Fernández-del-Carmen A, Orzáez D (2020) Pilot production of SARS-CoV-2 related proteins in plants: a proof of concept for rapid repurposing of indoor farms into biomanufacturing facilities. Front Plant Sci 11:612781. https://doi.org/10.3389/fpls.2020.612781 - DOI - PubMed - PMC
-
- Donini M, Marusic C (2019) Current state-of-the-art in plant-based antibody production systems. Biotechnol Lett 41:335–346. https://doi.org/10.1007/s10529-019-02651-z - DOI - PubMed
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous